Mark Madden
About Mark H. Madden
Mark H. Madden (age 67) is Chief Strategy Officer and a director of WinVest Acquisition Corp. (WINV). He has served as CSO since May 2021 and as a director since September 14, 2021, bringing decades of global investment management and corporate finance experience (Pioneer, OppenheimerFunds, TCW). He holds a BS from Trinity College and an MBA from the University of Virginia Darden School of Business . WINV’s board is classified; Madden is a Class I director whose term expires at the first annual meeting (which the company has not yet held) .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Pioneer Investments; OppenheimerFunds; TCW Group | Senior investment leadership roles overseeing portfolio managers, analysts, product, risk, compliance | Prior roles (dates not specified) | Led multi‑billion investment platforms, global oversight |
| Covenant Advisors LLC | Managing Partner | 2012–present | Investment firm leadership |
| BWS Partners LLC | Managing Member | 2016–present | Investment/finance leadership |
External Roles
| Organization | Role | Tenure | Notes |
|---|---|---|---|
| Clozex Medical, Inc. (private) | Treasurer, Corporate Secretary, director; more recently Chair | Since 2018 | Medical device (wound closure) company board leadership |
Board Governance
- Independence: Madden is not independent; WINV has determined only Kramer, McGowan, Pentland, and Schmidt are independent directors under Nasdaq/SEC rules .
- Committee assignments: Madden is not listed on the Audit Committee (McGowan—chair, Schmidt, Kramer) or Compensation Committee (Kramer—chair, McGowan) . WINV has no standing nominating committee; independent directors handle nominations .
- Board structure: 7‑member, staggered (Class I: Madden, McGowan, Pentland). The company may not hold an annual meeting until after a business combination .
- Context: WINV was delisted from Nasdaq in March 2025 and trades on OTC (WINV/rights/units/warrants), heightening governance and liquidity risk .
Fixed Compensation
| Component | Structure | Notes |
|---|---|---|
| Director/Executive cash compensation | None prior to business combination | “No executive officer or director has received any cash compensation” to date; only expense reimbursement permitted . |
| Office/admin fee to Sponsor | $10,000/month | Paid to Sponsor for office space and admin support (not paid to individual directors) . |
Performance Compensation
- None disclosed. WINV has not granted RSUs/PSUs/options to directors; any post‑combination compensation would be set by a committee of independent directors and disclosed at the time of de‑SPAC .
Other Directorships & Interlocks
- Current external board: Clozex Medical, Inc. (private) .
- No disclosed public company interlocks or related‑party transactions involving Madden beyond standard SPAC structures (see related-party/SPAC incentives below).
Expertise & Qualifications
- Capital markets and global investing leadership; built and managed multi‑billion portfolios; corporate finance and investment banking experience; strategic roles across 35+ countries .
Equity Ownership
| Holder | Security | Amount | % of Outstanding | As of |
|---|---|---|---|---|
| Mark H. Madden | Common stock (founder shares transferred to directors) | 28,000 | <1% | May 9, 2024 |
Notes:
- Prior to the IPO, the Sponsor transferred an aggregate 277,576 founder shares to directors for no cash consideration; such founder shares (including Madden’s) will be worthless if no business combination is completed, creating an incentive misalignment versus public investors .
Governance Assessment
-
Strengths:
- Deep capital markets and investment oversight experience; credible financial stewardship on a SPAC board .
- Not on Audit or Compensation—reduces concentration of power among executives; independent directors chair both committees .
-
Concerns/RED FLAGS:
- Independence: As CSO and director, Madden is not independent; WINV’s board relies on a subset of independents for committee work .
- Founder-share incentive: Madden beneficially owns 28,000 founder shares; founder shares were acquired at nominal cost and become worthless if no deal is closed, potentially biasing decision‑making toward completing a transaction regardless of quality .
- SPAC/Listing risk: WINV failed to meet Nasdaq deadlines and was delisted to OTC in March 2025, which can impair governance oversight, shareholder engagement, liquidity, and investor protections .
- Annual meeting/tenure clarity: Classified board with no annual meeting likely before a business combination; limits routine shareholder accountability .
- Sponsor influence/financing: Significant Sponsor ownership and extension loans; insiders collectively own ~91.7% of shares as of the 2025 proxy context, magnifying insider control and potential conflicts .
Overall, Madden brings substantive financial expertise but is an executive (non‑independent) director with founder‑share incentives in a SPAC confronting delisting and multiple deadline extensions—factors that warrant heightened scrutiny of deal quality, related‑party risks, and board independence.
Equity Ownership & Alignment Details
| Item | Detail |
|---|---|
| Total beneficial ownership | 28,000 shares; <1% of outstanding |
| Ownership form | Founder shares transferred by Sponsor to directors (no cash consideration) |
| Pledging/hedging | Not disclosed |
| Section 16 compliance | WINV reports officers and directors complied with Section 16(a) filing requirements for FY2024 |
Employment & Contracts
- Start dates: CSO since May 2021; director since Sept 14, 2021 .
- Agreements: WINV discloses no executive employment contracts or severance/termination benefits; any future compensation post‑combination to be set by independent compensation committee .
Related‑Party/Conflict Highlights
- Founder shares & incentives: Sponsor/director founder shares acquired at nominal cost; risk factor explicitly notes insiders could profit even if the acquired company later underperforms .
- Sponsor support & control: Sponsor receives monthly office/admin fee; has extended multiple promissory notes to fund deadline extensions; insiders collectively hold a controlling voting position, enabling approvals without public support .
Director Compensation (Structure)
| Element | Policy | Status |
|---|---|---|
| Cash retainer/fees | None pre‑combination | |
| Equity awards (RSUs/PSUs/options) | None disclosed pre‑combination | |
| Expense reimbursement | Permitted |
No meeting fee or committee‑chair premiums disclosed; independent directors chair audit/compensation; Madden is not on those committees .
Notes on Attendance & Engagement
- WINV has not held an annual meeting and may not do so until after a business combination; the company did not disclose per‑director board/committee attendance metrics in the 10‑K .
Risk Indicators & Red Flags (Director‑relevant)
- Non‑independence (executive director) .
- Founder‑share incentive misalignment .
- Delisting to OTC and ongoing extension/delays to complete a deal .
- Concentrated insider control—approval of key proposals without public votes .
All citations: .